Study Evaluating InductOs in Diaphyseal Tibia Fractures

Wyeth is now a wholly owned subsidiary of Pfizer277 enrolled

Overview

Demonstrate a larger proportion of subjects with healed fractures among subjects treated with InductOs and reamed, locked intramedullary nailing compared to subjects treated with reamed, locked intramedullary nailing alone.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

277

Conditions

Tibial Fractures

Interventions

InductOsDRUG

InductOs is rhBMP-2/ACS 1.5 mg/ml implanted once at the time of definitive fracture coverage

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects with acute open tibial shaft fractures (Gustilo Type I, II, IIIA, or IIIB) who require surgical management with reamed, statically locked intramedullary nail fixation and who are at low risk for amputation. * Subjects should be at least 18 years of age, be skeletally mature, and be able to provide written informed consent. * Initial fracture stabilization and wound debridement should occur within 1 day after injury and DFC should occur within 14 days after injury. Exclusion Criteria: * Planned treatment for the fracture should not include further procedures to promote fracture healing. After 16 weeks have elapsed since DFC, unanticipated procedures to promote fracture healing are permitted as clinically indicated. * Presence of fracture distraction \> 2 mm following definitive fracture fixation. * Presence of purulent drainage from the fracture site or evidence of active osteomyelitis.

Locations (27)

Unnamed facility

Ghent, Belgium

Unnamed facility

Turku, Finland

Outcomes

Primary Outcomes

Number of Patients With Healed Fractures

Patients categorized by investigator as healed, not healed, no outcome (using pre-specified criteria). Healed: no tenderness at fracture site or pain with weight bearing, presence of bridging callus or disappearance of fracture lines, no hardware failure, no secondary intervention to promote fracture healing. Not healed: diagnosis of delayed union or nonunion, hardware failure, secondary intervention procedure for fracture healing recommended or performed, or conduct of procedure that may interfere with fracture healing. No outcome: subjects who did not achieve either healed or not healed.

Time frame: 13 and 20 weeks

Secondary Outcomes

Number of Patients Achieving Combined Clinical and Radiographic Endpoint (CCRE)

Patients categorized as Success or Failure of CCRE. Success defined as a fracture judged to be both clinically healed by clinical investigator, "healed" (see primary outcome), and radiographically united by independent, blinded radiology panel, "united." Patients deemed "not healed" or "not united" were assessed as failures.

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.